Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study

Published:2016-04 Issue: Volume:140 Page:30-35
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Tofler G.H.,Massaro J.,O'Donnell C.J.,Wilson P.W.F.,Vasan R.S.,Sutherland P.A.,Meigs J.B.,Levy D.,D'Agostino R.B.

Funder

AHA

National Institutes of Health

National Heart, Lung and Blood Institute's Framingham Heart Study

Ducker Bequest and Heart Research Australia

Publisher

Elsevier BV

Subject

Hematology

Reference36 articles.

1. Plasminogen activator inhibitor type 1 and coronary artery disease;Kohler;N. Engl. J. Med.,2000

2. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction;Hamsten;Lancet,1987

3. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study;Folsom;Art Thromb Vasc Biol,2001

4. Assessment of hemostatic risk factors in predicting arterial thrombotic events;Feinbloom;Art Thromb Vasc Biol,2005

5. PAI-1 and the metabolic syndrome;Alessi;Arterioscl Thromb Vasc Biol,2006

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood coagulation in Prediabetes clusters–impact on all-cause mortality in individuals undergoing coronary angiography;Cardiovascular Diabetology;2024-08-22

2. Difficulties in detecting and differential diagnosis of dilated cardiomyopathy in young children;Meditsinskiy sovet = Medical Council;2024-08-06

3. Proteomic biomarkers related to obesity in heart failure with reduced ejection fraction and their associations with outcome;Obesity;2024-07-22

4. Liver involvement in presence of heart disease and heart involvement in presence of liver disease: a conundrum;Minerva Gastroenterology;2024-07

5. Identification of distinct and shared biomarker panels in different manifestations of cerebral small vessel disease through proteomic profiling;2024-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3